Marinomed Biotech AG (MARI.VI)
EUR 12.4
(3.33%)
EUR 12.4
(3.33%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.79 Million EUR | -6.21% |
| 2022 | -6.39 Million EUR | -8.6% |
| 2021 | -5.89 Million EUR | 1.98% |
| 2020 | -6.01 Million EUR | 16.72% |
| 2019 | -7.21 Million EUR | 40.34% |
| 2018 | -12.09 Million EUR | -408.66% |
| 2017 | -2.37 Million EUR | -20.42% |
| 2016 | -1.97 Million EUR | -39.7% |
| 2015 | -1.41 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.13 Million EUR | -78.84% |
| 2023 FY | -6.79 Million EUR | -6.21% |
| 2023 Q1 | -2.05 Million EUR | -238.28% |
| 2023 Q2 | -1.45 Million EUR | 29.51% |
| 2023 Q3 | -2.09 Million EUR | -44.07% |
| 2023 Q4 | -1.19 Million EUR | 43.06% |
| 2022 Q1 | -1.83 Million EUR | -546.45% |
| 2022 FY | -6.39 Million EUR | -8.6% |
| 2022 Q4 | -608.9 Thousand EUR | 68.76% |
| 2022 Q3 | -1.94 Million EUR | 2.65% |
| 2022 Q2 | -2 Million EUR | -8.96% |
| 2021 Q1 | -2.09 Million EUR | -71.23% |
| 2021 Q3 | -1.92 Million EUR | 15.66% |
| 2021 Q4 | 411.6 Thousand EUR | 121.38% |
| 2021 FY | -5.89 Million EUR | 1.98% |
| 2021 Q2 | -2.28 Million EUR | -8.9% |
| 2020 Q1 | -1.57 Million EUR | -48.02% |
| 2020 Q3 | -1.55 Million EUR | 5.91% |
| 2020 Q4 | -1.22 Million EUR | 21.37% |
| 2020 FY | -6.01 Million EUR | 16.72% |
| 2020 Q2 | -1.65 Million EUR | -5.05% |
| 2019 Q2 | -1.66 Million EUR | 48.61% |
| 2019 Q1 | -3.23 Million EUR | 60.88% |
| 2019 Q4 | -1.06 Million EUR | 14.74% |
| 2019 FY | -7.21 Million EUR | 40.34% |
| 2019 Q3 | -1.24 Million EUR | 25.04% |
| 2018 Q1 | -1.22 Million EUR | -551.88% |
| 2018 FY | -12.09 Million EUR | -408.66% |
| 2018 Q4 | -8.28 Million EUR | -370.31% |
| 2018 Q3 | -1.76 Million EUR | -111.99% |
| 2018 Q2 | -830.74 Thousand EUR | 32.05% |
| 2017 Q4 | -187.54 Thousand EUR | 0.0% |
| 2017 FY | -2.37 Million EUR | -20.42% |
| 2016 FY | -1.97 Million EUR | -39.7% |
| 2015 FY | -1.41 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|